Health Xtra Case Study | Dr. Amit Singh, Redcliffe Labs: When TB Testing Revealed More Than Expected

Case Overview

• A 48-year-old woman presented with symptoms including fatigue, nausea, night sweats, fever, and weight loss, prompting further evaluation for tuberculosis (TB).
• Her sample tested positive for Mycobacterium tuberculosis (MTB), confirming the presence of TB.
• However, detecting TB was only the first step. It was also important to understand whether the bacteria were resistant to the medicines being considered for treatment.
• Testing showed that the bacteria were sensitive to rifampicin but resistant to isoniazid.
• This indicated isoniazid-resistant, rifampicin-susceptible TB, also known as isoniazid mono-resistant TB.
• The case, discussed by Dr. Amit Singh, Consultant Microbiologist at Redcliffe Labs, highlights why identifying the specific drug-resistance pattern matters when understanding an unexpected treatment outcome.

The Case: When Detecting TB Was Only the Beginning

A 48-year-old woman presented with fatigue, nausea, night sweats, fever, and weight loss. These symptoms prompted further evaluation for tuberculosis. Her sample was tested using MDR-TB BD MAX, a molecular diagnostic test that can detect Mycobacterium tuberculosis and assess resistance to important TB medicines. The test detected Mycobacterium tuberculosis. But the report revealed something more.

The bacteria were: Sensitive to rifampicin, Resistant to isoniazid

This meant that the patient had isoniazid mono-resistant TB.

In the case discussed by Dr. Amit Singh, Consultant Microbiologist at Redcliffe Labs, the patient also experienced an unexpected treatment outcome, making it important to understand the underlying drug-resistance pattern. The additional testing provided an important piece of information that helped explain the case.

For complete details on the case, test findings, and the role of MDR-TB BD MAX, watch the complete video featuring Dr. Amit Singh, Consultant Microbiologist, Redcliffe Labs.

 Watch the complete case discussion.

What Did the Test Reveal?

A TB diagnosis answers an important question:

Is TB present?

In this case: Yes, Mycobacterium tuberculosis was detected.

But there was another question that mattered just as much:

Is the TB bacteria resistant to any of the medicines used to treat it?

The testing showed:

Test Finding	Result
Mycobacterium tuberculosis	Detected
Rifampicin	Sensitive
Isoniazid	Resistant
Resistance pattern	Isoniazid mono-resistant TB

So, while TB was present, the bacteria were resistant to isoniazid.

That additional information helped provide a more complete understanding of the patient's condition.

Why Was This Finding Important?

TB treatment involves multiple medicines, and knowing whether the bacteria are susceptible to them matters when planning treatment.

In this case:

Rifampicin → Sensitive

Isoniazid → Resistant

If the assessment had focused only on rifampicin, isoniazid resistance could have gone undetected. This is why the case highlights the importance of checking both rifampicin and isoniazid resistance when clinically indicated.

The important question isn't only: "Does the patient have TB?"

It can also be:

"What do we know about the drug-resistance pattern?"

Understanding this pattern can provide the treating doctor with additional information when deciding on the appropriate treatment approach.

What Is Isoniazid Mono-Resistant TB?

Let's simplify the terminology.

Isoniazid mono-resistance means the TB bacteria are resistant to isoniazid but remain susceptible to rifampicin.

So:

Isoniazid

Resistant

Rifampicin

Sensitive

This is different from multidrug-resistant tuberculosis (MDR-TB).

Is Isoniazid-Resistant TB the Same as MDR-TB?

No. This distinction is important. MDR-TB specifically refers to TB that is resistant to both isoniazid and rifampicin.

In this case:

Isoniazid → Resistant

Rifampicin → Sensitive

Therefore, the patient had isoniazid-resistant, rifampicin-susceptible TB, rather than MDR-TB.

Different drug-resistance patterns can have different treatment implications, which is why identifying the specific pattern matters.

Why Can TB Drug Resistance Be Missed?

This case raises an important question:

If TB is detected and rifampicin is sensitive, why test further?

Because resistance to one medicine does not necessarily mean resistance to another.

TB bacteria can show different resistance patterns.

A patient may have:

• TB with no detected drug resistance
• Resistance to a single TB medicine
• Resistance to multiple TB medicines
• Rifampicin-resistant TB
• MDR-TB

The specific resistance pattern needs to be established through appropriate diagnostic testing.

This is why a TB diagnosis should not always stop at:

"TB Detected."

The next question may be:

"What do we know about its drug resistance?"

How Did MDR-TB BD MAX Help in This Case?

The MDR-TB BD MAX is an automated molecular test designed to detect Mycobacterium tuberculosis and assess resistance to rifampicin and isoniazid.

In this case, it provided three important pieces of information:

1. TB was detected

The test identified Mycobacterium tuberculosis in the patient's sample.

2. Rifampicin resistance was not detected

The bacteria were sensitive to rifampicin.

3. Isoniazid resistance was detected

The bacteria were resistant to isoniazid.

Together, these findings established the specific resistance pattern:

MTB Detected + Rifampicin Sensitive + Isoniazid Resistant

That is much more informative than simply knowing that TB was present.

Why Does Testing for Both Rifampicin and Isoniazid Matter?

One of the most important learnings from this case is that one resistance marker may not tell the complete story.

If testing identifies rifampicin sensitivity but does not assess isoniazid resistance, an important part of the resistance profile may remain unknown.

As Dr. Amit Singh highlights, this can be particularly relevant when trying to understand an unexpected treatment outcome.

The case therefore raises a simple but important diagnostic question:

Are we checking enough to understand the resistance pattern?

For appropriate patients, testing for resistance to both rifampicin and isoniazid can provide a more complete picture.

From Symptoms to a More Complete Diagnosis

The patient's journey can be understood in a simple sequence:

Symptoms

Fever, night sweats, fatigue, nausea, and weight loss

↓

TB Testing

Mycobacterium tuberculosis detected

↓

Drug-Resistance Testing

Resistance to specific TB medicines assessed

↓

Key Finding

Isoniazid-resistant + rifampicin-sensitive

↓

More Complete Diagnosis

Isoniazid-resistant, rifampicin-susceptible TB

↓

Clinical Action

The findings were shared with the relevant department for appropriate clinical consideration.

What Does This Mean for Patients?

If you or someone in your family is being evaluated for TB, a positive TB result may not always be the end of the diagnostic journey.

Depending on the clinical situation, your doctor may also need to understand:

Is the TB bacteria resistant to any of the medicines being considered?

This can be particularly relevant when:

• Treatment is not producing the expected response
• Drug-resistant TB is suspected
• There is a history of previous TB treatment
• There are other clinical reasons to investigate drug resistance

The appropriate tests will depend on the individual patient's clinical situation.

The key message is simple:

Finding TB is important. Understanding its drug-resistance pattern can be equally important.

What This Case Teaches Us About TB Testing

This case is not just about one patient.

It demonstrates a broader lesson about TB diagnosis:

A positive TB result tells you what infection is present.

Drug-resistance testing can tell you more about how that infection may respond to treatment.

In this case, the additional finding of isoniazid resistance despite rifampicin sensitivity provided an important insight into the patient's treatment outcome.

It also demonstrates why looking at the broader resistance pattern can help doctors make more informed treatment decisions.

The Key Takeaway

TB Detection Is Only One Part of the Diagnosis

For this patient, the diagnostic journey revealed:

TB → Detected

Rifampicin → Sensitive

Isoniazid → Resistant

That combination pointed to isoniazid-resistant, rifampicin-susceptible TB.

The case highlights an important principle:

In TB, knowing the infection is present matters. Knowing its drug-resistance pattern can provide equally important information for treatment decisions.

As Dr. Amit Singh's case discussion demonstrates, looking beyond a single resistance marker can sometimes reveal the missing piece behind an unexpected treatment outcome.

Frequently Asked Questions About TB and Drug-Resistance Testing

1. What is drug-resistant TB?

Drug-resistant TB is tuberculosis caused by Mycobacterium tuberculosis bacteria that are resistant to one or more medicines used to treat TB. The type of drug-resistant TB depends on which medicines the bacteria resist.

2. What is MDR-TB?

MDR-TB, or multidrug-resistant tuberculosis, is TB caused by bacteria that are resistant to at least isoniazid and rifampicin, two important medicines used to treat TB.

3. What is isoniazid-resistant TB?

Isoniazid-resistant TB occurs when Mycobacterium tuberculosis is resistant to isoniazid. When the bacteria remain susceptible to rifampicin, it is called isoniazid-resistant, rifampicin-susceptible TB.

4. Is isoniazid-resistant TB the same as MDR-TB?

No. MDR-TB involves resistance to both isoniazid and rifampicin. Isoniazid-resistant, rifampicin-susceptible TB involves resistance to isoniazid while the bacteria remain susceptible to rifampicin.

5. What is drug susceptibility testing for TB?

Drug susceptibility testing (DST) determines whether Mycobacterium tuberculosis is susceptible or resistant to specific TB medicines. Molecular and other laboratory methods can identify drug resistance.

6. Why is drug-resistance testing important in TB?

Drug-resistance testing helps identify whether TB bacteria are resistant to specific medicines. This gives the treating doctor additional information when considering the appropriate treatment approach.

7. What is the MDR-TB BD MAX test?

MDR-TB BD MAX is an automated molecular diagnostic test that can detect Mycobacterium tuberculosis and assess resistance to rifampicin and isoniazid.

8. What are the common symptoms of TB?

Common symptoms of TB can include persistent cough, fever, night sweats, unexplained weight loss, fatigue, and loss of appetite. Symptoms can vary depending on the affected body part.

If symptoms persist or are concerning, consult a healthcare professional.

9. How is TB diagnosed?

TB diagnosis depends on the patient's symptoms, clinical history, and the suspected site of infection. Depending on the situation, doctors may use molecular tests, microscopy, culture, imaging, and other diagnostic methods.

10. Can drug-resistant TB be treated?

Yes. Drug-resistant TB can be treated. However, the treatment approach depends on the specific resistance pattern and other individual clinical factors. A doctor should determine the appropriate treatment based on the patient's test results and clinical condition.

11. Is TB curable?

TB is treatable and curable when appropriate treatment is prescribed and completed as directed. The treatment approach can vary depending on whether the TB is drug-sensitive or drug-resistant.

12. Why is early detection of drug-resistant TB important?

Early identification of drug resistance gives doctors important information about the TB bacteria and helps inform treatment decisions. Early understanding of resistance is especially important when treatment isn't producing the expected response.

Health Xtra by Redcliffe Labs

Every Test Tells a Story.

Sometimes, the most important part of the story is what the first result doesn't tell you.

This case study is intended for educational purposes. A qualified healthcare professional should make test selection and treatment decisions based on the patient's clinical condition, diagnostic findings, and applicable clinical guidelines.